Jiaru Fang
Overview
Explore the profile of Jiaru Fang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Han H, Ying X, Chen Q, Fang J, Xu D, Lyu X, et al.
Biosens Bioelectron
. 2025 Jan;
274:117197.
PMID: 39874921
Preterm birth (PTB) remains a leading cause of neonatal morbidity and mortality, with inflammation-induced PTB posing a significant challenge due to its complex pathophysiology. To address this, we developed an...
2.
Chen J, Lyu X, Yuan Q, Qin C, Yu H, Xu D, et al.
Biosens Bioelectron
. 2024 Dec;
271:117045.
PMID: 39657554
Myocardial infarction is a leading cause of morbidity and mortality associated with cardiovascular diseases worldwide. Although novel medications and treatments greatly alleviate patient suffering, challenges related to prognostic limit the...
3.
Lei X, Fang J, Zhang Z, Li Z, Xu Y, Xie Q, et al.
Plant Cell Environ
. 2024 Oct;
48(2):1088-1106.
PMID: 39403882
Salt stress is the main factor limiting the large-scale cultivation of Shanxin poplar; therefore, improving its salt tolerance is crucial. In this study, we identified and characterized a CRF gene...
4.
Xu D, Lyu X, Han H, Fang J, Xue J, Zheng J, et al.
Nano Lett
. 2024 Aug;
24(36):11302-11310.
PMID: 39213538
Bradyarrhythmia poses a serious threat to human health, with chronic progression causing heart failure and acute onset leading to sudden death. In this study, we develop a scalable drug-mimicking nanoplasmonic...
5.
Lyu X, Fang J, Liu D, Wu Q, Li Y, Qin C, et al.
Biosens Bioelectron
. 2024 Jul;
262:116554.
PMID: 38971038
Bradyarrhythmia, a life-threatening cardiovascular disease, is an increasing burden for the healthcare system. Currently, surgery, implanted device, and drug are introduced to treat the bradyarrhythmia in clinical practice. However, these...
6.
Zheng J, Fang J, Xu D, Liu H, Wei X, Qin C, et al.
ACS Nano
. 2024 Jun;
18(24):15332-15357.
PMID: 38837178
Cardiovascular diseases (CVDs) are the leading cause of mortality and therefore pose a significant threat to human health. Cardiac electrophysiology plays a crucial role in the investigation and treatment of...
7.
Xiang Y, Shi K, Li Y, Xue J, Tong Z, Li H, et al.
Nanomicro Lett
. 2024 Feb;
16(1):132.
PMID: 38411852
The development of precise and sensitive electrophysiological recording platforms holds the utmost importance for research in the fields of cardiology and neuroscience. In recent years, active micro/nano-bioelectronic devices have undergone...
8.
Wang H, Xue J, Li Y, Shi K, Fang J, Zheng J, et al.
Nano Lett
. 2023 Dec;
23(24):11884-11891.
PMID: 38064276
Nanostructures are powerful components for the development of high-performance nanodevices. Revealing and understanding the cell-nanostructure interface are essential for improving and guiding nanodevice design for investigations of cell physiology. For...
9.
Qin C, Xu D, Han H, Fang J, Wang H, Liu Y, et al.
Nano Lett
. 2023 Dec;
23(24):11850-11859.
PMID: 38051785
Cardiac oxidative stress is a significant phenotype of myocardial infarction disease, a leading cause of global health threat. There is an urgent need to develop innovative therapies. Nanosized extracellular vesicle...
10.
Han H, Qin C, Xu D, Kar S, Castro F, Wang Z, et al.
Biosens Bioelectron
. 2023 Dec;
246:115860.
PMID: 38039735
Action potentials play a pivotal role in diverse cardiovascular physiological mechanisms. A comprehensive understanding of these intricate mechanisms necessitates a high-fidelity intracellular electrophysiological investigative approach. The amalgamation of micro-/nano-electrode arrays...